ExplantLab

ExplantLab is a UK orthogenomic biotech company focused on improving outcomes in orthopaedic implants through patient-specific diagnostics and implant failure analysis. The company markets Orthotype, a patented genetic testing approach used in clinical practice to assess risk of adverse responses and implant failure, particularly around cobalt-chrome orthopaedic implants. It also operates a large independent explant retrieval and analysis service that investigates failed implants and provides reports for clinicians, hospitals, patients, and manufacturers. The business sits at the intersection of biotechnology, genomics, orthopaedics, and medical devices, with a personalized-medicine approach aimed at reducing chronic pain, revision surgery, and downstream healthcare costs.